| Name | Begelomab |
|---|
| Description | Begelomab (SAND-26) is a murine IgG2b monoclonal antibody against DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy[1][2]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |